BR0007980A - Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha - Google Patents

Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha

Info

Publication number
BR0007980A
BR0007980A BR0007980-4A BR0007980A BR0007980A BR 0007980 A BR0007980 A BR 0007980A BR 0007980 A BR0007980 A BR 0007980A BR 0007980 A BR0007980 A BR 0007980A
Authority
BR
Brazil
Prior art keywords
crosslinked
derivatives
hyaluronic acid
itself
preparation
Prior art date
Application number
BR0007980-4A
Other languages
English (en)
Inventor
Xiaobin Zhao
Original Assignee
Vitrolife Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10847046&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0007980(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitrolife Uk Ltd filed Critical Vitrolife Uk Ltd
Publication of BR0007980A publication Critical patent/BR0007980A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE DERIVADOSMULTI-RETICULADOS DE áCIDO HIALURÈNICO, HA MULTIRETICULADO, HA RETICULADO EM SI PRóPRIO, PRODUTO,E, USO DE HA. A presente invenção refere-se a um processo paraa produção de derivados de ácido hialurónico (HA) reticulados, emparticular derivados do ácido hialurónico multiplamente, p. ex.,duplamente reticulados. A invenção também fornece novosderivados do HA reticulados, produtos contendo-os e seus usosem aplicações médicas, farmacêuticas e cosméticas.
BR0007980-4A 1999-02-03 2000-02-03 Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha BR0007980A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9902412.7A GB9902412D0 (en) 1999-02-03 1999-02-03 Process
PCT/GB2000/000321 WO2000046253A1 (en) 1999-02-03 2000-02-03 Process for the production of multiple cross-linked hyaluronic acid derivatives

Publications (1)

Publication Number Publication Date
BR0007980A true BR0007980A (pt) 2001-10-30

Family

ID=10847046

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007980-4A BR0007980A (pt) 1999-02-03 2000-02-03 Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha

Country Status (15)

Country Link
US (3) US7385052B2 (pt)
EP (1) EP1149116B9 (pt)
JP (1) JP2002536466A (pt)
CN (1) CN1200951C (pt)
AT (1) ATE315050T2 (pt)
AU (1) AU773518B2 (pt)
BR (1) BR0007980A (pt)
CA (1) CA2361981C (pt)
DE (2) DE1149116T1 (pt)
DK (1) DK1149116T5 (pt)
ES (1) ES2181608T5 (pt)
GB (1) GB9902412D0 (pt)
MX (1) MXPA01007876A (pt)
NZ (1) NZ512993A (pt)
WO (1) WO2000046253A1 (pt)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
US6288043B1 (en) * 1999-06-18 2001-09-11 Orquest, Inc. Injectable hyaluronate-sulfated polysaccharide conjugates
AU2002214443B2 (en) 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
WO2004046200A1 (ja) * 2002-11-21 2004-06-03 Chugai Seiyaku Kabushiki Kaisha 薬物徐放担体
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
AU2003901834A0 (en) * 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
WO2005054302A1 (ja) * 2003-12-05 2005-06-16 Chugai Seiyaku Kabushiki Kaisha 薬物担体及びその製造方法
GB0329907D0 (en) * 2003-12-23 2004-01-28 Innomed Ltd Compositions
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
WO2005113608A1 (en) * 2004-05-20 2005-12-01 Mentor Corporation Method of covalently linking hyaluronan and chitosan
US20050281880A1 (en) * 2004-05-20 2005-12-22 Wei Wang Methods for making injectable polymer hydrogels
US7993678B2 (en) * 2005-09-26 2011-08-09 Novozymes Biopolymer A/S Hyaluronic acid derivatives
DE102006013594A1 (de) * 2006-03-22 2007-09-27 Biopolymer Gmbh & Co. Kg Quervernetzte Gele von Hyaluronsäure und deren Verwendung
CN101153061A (zh) * 2006-09-29 2008-04-02 北京普麦迪克生物技术研究所 一种透明质酸及其二次交联形成凝胶的方法
FR2918377B1 (fr) 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
JP4460617B2 (ja) * 2007-09-28 2010-05-12 株式会社資生堂 膨潤性架橋ヒアルロン酸粉末及びその製造方法
FR2924615B1 (fr) 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
ITMC20080129A1 (it) * 2008-07-08 2008-10-07 Phitogen Holding S P A Sintesi di acido ialuronico reticolato con inibitore della ialuronidasi microincapsulato.
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US9371402B2 (en) 2009-04-09 2016-06-21 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
US8968785B2 (en) * 2009-10-02 2015-03-03 Covidien Lp Surgical compositions
KR101122163B1 (ko) 2009-12-01 2012-03-16 (주)셀인바이오 아토피 피부염에 효과적인 히알루론산 유도체 및 그 제조방법
AU2011229730B2 (en) 2010-03-22 2016-01-07 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
IT1399508B1 (it) * 2010-04-22 2013-04-19 Nobil Bio Ricerche Srl Dispositivo per impianto con proprieta' antibatteriche e superficie multifunzionale
ITAN20110138A1 (it) 2011-10-12 2012-01-11 Regenyal Lab S R L Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
JP2014521492A (ja) * 2011-11-11 2014-08-28 エムアイビーエイ メディカル インコーポレイテッド 注入充填剤（フィラー）｛ｉｎｊｅｃｔａｂｌｅｆｉｌｌｅｒ｝
CN103181902B (zh) * 2011-12-30 2016-06-08 张文芳 一种凝胶微球及其质控方法
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
CN102863631B (zh) * 2012-09-29 2013-11-13 杭州嘉伟生物制品有限公司 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法
CN103055353B (zh) * 2013-01-21 2014-12-24 华熙福瑞达生物医药有限公司 一种手术用防粘连膜的制备方法
BR112015031457A2 (pt) * 2013-06-28 2017-07-25 Galderma Sa processo para preparar um produto do ácido hialurônico reticulado
EP3013865B1 (en) * 2013-06-28 2019-10-23 Galderma S.A. Method for manufacturing a shaped cross-linked hyaluronic acid product
JP6322192B2 (ja) 2013-07-08 2018-05-09 デンカ株式会社 コアシェル型架橋ヒアルロン酸ゲル粒子、その製造方法及び医用材料
US9572832B2 (en) * 2013-08-29 2017-02-21 Holy Stone Healthcare Co., Ltd. Compound of glycosaminoglycan and its fabrication method as well as application
US9155757B2 (en) 2013-10-07 2015-10-13 Laboratoires Vivacy Methods and kits for treating vaginal and vulvar vestibule mucosa disorders
FR3015290B1 (fr) 2013-12-23 2017-01-13 Lab Vivacy Compositions d'acide hyaluronique compreant de la mepivacaine
CN103920182B (zh) * 2014-04-16 2015-10-21 华熙福瑞达生物医药有限公司 一种生物可吸收止血膜
WO2016057607A1 (en) * 2014-10-08 2016-04-14 Therakine Micronized hydrophilic cross-linked biopolymer systems and method of making same
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr) 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
US10130578B2 (en) 2015-07-23 2018-11-20 Johnson & Johnson Consumer Inc. Topical delivery of skin compositions having low pH
WO2017102001A1 (fr) 2015-12-16 2017-06-22 Vplus International Sa Composition d'acide hyaluronique pour injections peniennes
EP3397651B1 (en) 2015-12-29 2020-05-06 Galderma S.A. Carbohydrate crosslinker
PT3623390T (pt) 2016-05-31 2023-10-27 Galderma Sa Reticulador de hidrato de carbono
CN106279729A (zh) * 2016-08-26 2017-01-04 北京大清生物技术有限公司 一种透明质酸交联凝胶及其制备方法与应用
KR20180027126A (ko) 2016-09-06 2018-03-14 (주)한국비엠아이 가교화 히알루론산 유도체 매트릭스가 포함된 지혈 조성물
FR3058064B1 (fr) 2016-10-28 2020-08-07 Lab Vivacy Composition a base d'acide hyaluronique comprenant de la mepivacaine
CZ2016826A3 (cs) 2016-12-22 2018-07-04 Contipro A.S. Léčivý prostředek s nosičem na bázi hyaluronanu a/nebo jeho derivátů, způsob výroby a použití
MX2020003976A (es) * 2017-10-12 2020-10-01 Solyplus Gmbh Procesamiento mecanico de biopolimeros.
KR102336680B1 (ko) * 2017-11-29 2021-12-08 주식회사 파마리서치 자극의 강도에 따라 변화하는 물성을 가지는 코어-쉘 구조의 히알루론산 겔 및 이의 제조방법
CN112334168A (zh) * 2018-05-03 2021-02-05 科尔普兰特有限公司 真皮填充剂和其应用
IT201800006127A1 (it) * 2018-06-07 2018-09-07 Sintesi di un gel iniettabile (filler) ad alta biocompatibilità a base di Ialuronato di sodio monofasico reticolato e Ialuronato di sodio lineare multifrazionato intercalato.
CN112807479B (zh) * 2018-08-20 2022-08-05 稳得希林(杭州)生物科技有限公司 多糖基组织粘合医用胶及其应用
CN110229357B (zh) * 2019-06-28 2022-03-11 浙江科技学院 一种交联透明质酸凝胶的制备方法
CA3160575A1 (en) 2019-12-02 2021-06-10 Johan Olsson High molecular weight esthetic compositions
CN111000796A (zh) * 2019-12-31 2020-04-14 瑞希(重庆)生物科技有限公司 一种透明质酸钠凝胶及其制备方法和应用
FR3111903B1 (fr) 2020-06-24 2022-12-02 Lab Vivacy Procede d’incorporation de composes organiques en solution au sein d’un hydrogel
FR3113522A1 (fr) 2020-08-20 2022-02-25 Laboratoires Vivacy procédé d’évaluation des caractéristiques rhéologiques d’un gel
CN112030566B (zh) * 2020-09-30 2022-10-21 山东华熙海御生物医药有限公司 一种依克多因缓释微囊及其制备方法和应用
CN114478831B (zh) * 2022-01-21 2023-06-27 湖南益安生物科技有限公司 一种高分子材料及其制备方法与应用
CN114716581A (zh) * 2022-03-25 2022-07-08 常州百瑞吉生物医药有限公司 一种多重改性透明质酸衍生物及其应用
FR3135399A1 (fr) 2022-03-30 2023-11-17 Laboratoires Vivacy émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse
CN116284886A (zh) * 2023-04-10 2023-06-23 上海其胜生物制剂有限公司 多重交联的凝胶体系及其产品、制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) † 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
SE452469B (sv) † 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5800541A (en) 1988-11-21 1998-09-01 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5356883A (en) † 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
GB9024223D0 (en) 1990-11-07 1990-12-19 Fermentech Ltd Production of hyaluronic acid
IT1260154B (it) 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
US5578661A (en) 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings
JP3420851B2 (ja) † 1994-12-06 2003-06-30 株式会社資生堂 癒着防止剤
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
US6060534A (en) * 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
US6472379B1 (en) † 1999-03-15 2002-10-29 Trustees Of Boston University Angiogenesis inhibition

Also Published As

Publication number Publication date
EP1149116B2 (en) 2016-03-30
ES2181608T3 (es) 2006-06-16
NZ512993A (en) 2004-02-27
US20090247741A1 (en) 2009-10-01
EP1149116A1 (en) 2001-10-31
US20050250939A1 (en) 2005-11-10
AU2307500A (en) 2000-08-25
DE60025328D1 (de) 2006-03-30
CN1342171A (zh) 2002-03-27
DK1149116T4 (en) 2016-04-25
ATE315050T2 (de) 2006-02-15
DE60025328T2 (de) 2006-09-28
MXPA01007876A (es) 2003-06-04
ES2181608T5 (es) 2016-07-22
EP1149116B9 (en) 2017-01-25
ES2181608T1 (es) 2003-03-01
ES2181608T9 (es) 2017-02-09
DK1149116T3 (da) 2006-05-15
US7385052B2 (en) 2008-06-10
CN1200951C (zh) 2005-05-11
DK1149116T5 (en) 2017-02-13
CA2361981A1 (en) 2000-08-10
DE60025328T3 (de) 2016-07-28
US8080641B2 (en) 2011-12-20
US20020091251A1 (en) 2002-07-11
DE1149116T1 (de) 2002-11-14
GB9902412D0 (en) 1999-03-24
EP1149116B1 (en) 2006-01-04
US7514541B2 (en) 2009-04-07
JP2002536466A (ja) 2002-10-29
CA2361981C (en) 2008-06-10
WO2000046253A1 (en) 2000-08-10
AU773518B2 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
BR0007980A (pt) Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha
BR0007985A (pt) Processo para a preparação de derivados multiplamente reticulados do ácido hialurÈnico (ha), ha multiplamente reticulado, ha reticulado em um ou mais polìmeros diferentes de ha, ha reticulado em um segundo polìmero, produto, e, uso de um derivado de ha multiplamente reticulado
DE60113121D1 (de) Herstellung von vernetzter hyaluronsäure und dessen hydrogel, die hergestellten produkte und deren verwendungen
YU31801A (sh) Amidi antranilne kiseline i njihova upotreba kao leka
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
BR0211601A (pt) Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos
BR9801652A (pt) Resorcinil-triazinas
BR9913617A (pt) Composições de reologia modificada e seus processos
BR9808427A (pt) Produto, processo de preparação e utilização do mesmo e composição farmacêutica
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
DE69831805D1 (de) Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
AU6997200A (en) No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
ID28365A (id) Turunan produk alami yang baru
HUP0402599A2 (hu) D vitamin analógok
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
YU4497A (sh) Novi heteroaril - oksazolidinoni
TR200102930T2 (tr) Ruhsal bozuklukların tedavisinde yararlı olan ilaçların üretiminde osanetat kullanımı
PT1232173E (pt) Derivados do acido fusidico
AU576107B2 (en) Isohexide-nucleoside
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
WO2002070537A3 (en) Fusidic acid derivatives

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: A-LIFE LIMITED (GB)

Free format text: ALTERADO DE: VITROLIFE UK LIMITED

B25G Requested change of headquarter approved

Owner name: A-LIFE LIMITED (GB)

Free format text: ANOTADAS AS ALTERACOES DE SEDE DO TITULAR REQUERIDAS NA PETICAO NO 052711/RJ DE 18/09/2003.

B25D Requested change of name of applicant approved

Owner name: MENTOR BIOPOLYMERS LIMITED (GB)

Free format text: ALTERA O NOME DE: A-LIFE LIMITED

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM O ART. 8O DA LEI NO 9.279, DE 14 DE MAIO DE 1996.

B09S Decision of refusal: publication cancelled [chapter 9.2.2 patent gazette]

Free format text: REFERENTE A RPI 2004 DE 02/06/2009.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: ASSIM SENDO, DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE NOVIDADE (ART. 8O COMBINADO COM ART. 11 DA LPI) E AO REQUISITO DE ATIVIDADE INVENTIVA (ART. 8O COMBINADO COM ART. 13 DA LPI).

B12B Appeal against refusal [chapter 12.2 patent gazette]